Form 4: Select Medical Vice Chairman Reports Stock Tax Withholding
Statement of Changes in Beneficial Ownership
David S. Chernow, Vice Chairman of Select Medical Holdings, disposed of 22,586 shares to satisfy tax obligations related to restricted stock vesting.
Summary
- David S. Chernow, Vice Chairman of Select Medical Holdings Corp (SEM), reported the disposition of 22,586 shares of common stock.
- The transaction occurred on April 30, 2026, at a price of $16.41 per share.
- The disposition was a mandatory tax withholding event incident to the vesting of restricted stock.
- Following this transaction, the reporting person retains beneficial ownership of 870,244 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative tax compliance action rather than a strategic or market-driven decision.
Positives
- The transaction was a routine administrative action related to tax obligations rather than a discretionary open-market sale.
- The reporting person maintains a significant equity stake of 870,244 shares in the company.
Negatives
- None; this is a standard regulatory filing for tax compliance.
Risks
- None; this filing pertains to internal tax compliance and does not reflect operational or market risks.
Future Outlook
Not applicable; this is a retrospective disclosure of a transaction.
Industry Context
StockSavvy.ai notes that Form 4 filings involving tax withholding upon the vesting of equity awards are standard industry practice for executive compensation and do not typically signal a change in management sentiment regarding company performance.
Comparison to Industry Standards
- The transaction aligns with standard executive compensation practices observed in the healthcare services sector.
- The use of net-settlement for tax obligations is a common mechanism used by executives at companies like HCA Healthcare and Tenet Healthcare.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Appointment of John F. Duggan as attorney-in-fact for Section 16 reporting. | 07/24/2025 | Administrative update to facilitate regulatory compliance. |
Stakeholder Impact
- No material impact on shareholders, employees, or creditors.
Next Steps
- No further actions required by the reporting person regarding this specific transaction.
Key Dates
| Date | Description |
|---|---|
| 07/24/2025 | Date of execution for the Limited Power of Attorney. |
| 04/30/2026 | Date of the reported stock transaction. |
| 05/01/2026 | Date of filing for the Form 4. |
Keywords
Select Medical, SEM, Form 4, Insider Trading, Tax Withholding, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.